Stealthyx focused on the development of the Prothyx technology platform as a vehicle for drug delivery The Prothyx platform also has the potential for delivery of other molecules including siRNA and small molecules which, together with the ability to deliver proteins and peptides, gives Stealthyx a broad opportunity for partnering along with those agreements presently in place with CRT and Biogenesis Bago The investment from The Wellcome Trust allowed Stealthyx to expand the application of the Prothyx platform to include small biologically active peptides